Dr. Athiya Agarwal has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Athiya Agarwal, part of the promoter group of Dr. Agarwal's Health Care Limited, has filed a disclosure with the exchange under Regulation 10(5) of the SEBI Takeover Regulations, 2011. This regulation pertains to inter se transfers of shares among promoters or members of the promoter group. The filing indicates that a share transfer within the promoter family has taken place, though the specific details (number of shares, direction, and parties involved) are not disclosed in the headline. Such filings are routine compliance requirements when shares move between promoter group entities.
This is largely a regulatory compliance filing and indicates reshuffling of shares within the promoter group rather than any change in overall promoter ownership. Shareholders need not be alarmed as it typically does not affect the company's market dynamics, though investors may want to check the detailed disclosure for the exact nature of the transfer.